تولید ژلاتین کپسول ایران
دکپسول | Stocks - Iran Fara Bourse (IFB)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 192,300 3.00
Close Price: 191,900
Financial Ratios
AGM
Interim
2026/06/28 Fiscal Year 2026/03/2012 Month | 2025/05/04 Fiscal Year 2025/03/2012 Month | 2024/05/05 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 36.62 | 41.75 | 45.74 | |
Gross Profit to Sales | 47.49 | 51.06 | 55.29 | |
Operating Margin | 48.39 | 51.98 | 56.44 | |
Gross Profit to Sales | 54.59 | 58.67 | 61.69 | |
Net Profit to Gross Profit | 67.08 | 71.15 | 74.14 | |
Return on Assets (ROA) | 29.95 | 31.83 | 43.55 | |
Return on Capital (%) | 1,796.71 | 1,439.72 | 1,142.28 | |
Return on Equity (ROE) | 52.13 | 46.66 | 80.89 | |
Working Capital Return | 108.09 | 102.73 | 125.56 | |
Fixed Asset Return | 92.64 | 79.98 | 183.41 | |
Loan Benefit Assessment | 1.74 | 1.47 | 1.86 | |
Current Ratio | 1.7 | 2.08 | 1.85 | |
Quick Ratio | 1.4 | 1.47 | 1.38 | |
Liquidity Ratio | 0.17 | 0.55 | 0.21 | |
Net Working Capital | 4,986,582 | 4,204,572 | 2,729,300 | |
Current Assets Ratio | 0.67 | 0.6 | 0.76 | |
Inventory Turnover | 123.22 | 166.14 | 192.6 | |
Receivables Collection Period | 103.89 | 105.23 | 88.8 | |
Inventory to Working Capital | 0.43 | 0.57 | 0.55 | |
Working Capital Turnover | 2.95 | 2.46 | 2.75 | |
Fixed Asset Turnover | 2.53 | 1.92 | 4.01 | |
Total Asset Turnover | 0.82 | 0.76 | 0.95 | |
Debt Ratio | 0.43 | 0.32 | 0.46 | |
Debt to Equity | 0.74 | 0.47 | 0.86 | |
Long-Term Debt to Equity | 0.05 | 0.05 | 0.1 | |
Current Debt to Equity | 0.69 | 0.42 | 0.76 | |
Equity Ratio | 57.44 | 68.21 | 53.84 | |
Debt Coverage Ratio | 10.96 | 12.88 | 4.64 |
